Short Interest in Vicarious Surgical Inc. (NYSE:RBOT) Declines By 31.2%

Vicarious Surgical Inc. (NYSE:RBOT) was the target of a large decrease in short interest in February. As of February 27th, there was short interest totaling 264,129 shares, a decrease of 31.2% from the February 12th total of 383,672 shares. Based on an average daily volume of 76,584 shares, the short-interest ratio is presently 3.4 days. Currently, 4.5% of the shares of the company are sold short. Currently, 4.5% of the shares of the company are sold short. Based on an average daily volume of 76,584 shares, the short-interest ratio is presently 3.4 days.

Vicarious Surgical Stock Up 7.2%

Shares of Vicarious Surgical stock traded up $0.04 on Monday, reaching $0.58. The company’s stock had a trading volume of 4,541 shares, compared to its average volume of 123,637. The company has a market capitalization of $3.80 million, a P/E ratio of -0.06 and a beta of 1.53. The stock has a 50-day moving average price of $1.98 and a 200-day moving average price of $3.59. Vicarious Surgical has a 52-week low of $0.27 and a 52-week high of $13.75.

Vicarious Surgical (NYSE:RBOT) last released its quarterly earnings results on Monday, March 9th. The company reported ($1.65) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($1.37) by ($0.28). Sell-side analysts forecast that Vicarious Surgical will post -10.89 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on the stock. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Vicarious Surgical in a report on Wednesday, January 21st. Wall Street Zen lowered shares of Vicarious Surgical from a “hold” rating to a “sell” rating in a research report on Saturday, March 7th. Finally, BTIG Research reiterated a “neutral” rating on shares of Vicarious Surgical in a research report on Friday, December 12th. Two research analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Reduce” and an average price target of $7.00.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in the business. DNB Asset Management AS raised its stake in shares of Vicarious Surgical by 12.1% in the second quarter. DNB Asset Management AS now owns 29,199 shares of the company’s stock valued at $219,000 after acquiring an additional 3,154 shares in the last quarter. Dimensional Fund Advisors LP raised its position in Vicarious Surgical by 22.1% in the 3rd quarter. Dimensional Fund Advisors LP now owns 19,975 shares of the company’s stock valued at $110,000 after purchasing an additional 3,615 shares in the last quarter. Geode Capital Management LLC raised its position in Vicarious Surgical by 26.0% in the 4th quarter. Geode Capital Management LLC now owns 40,494 shares of the company’s stock valued at $88,000 after purchasing an additional 8,344 shares in the last quarter. XTX Topco Ltd purchased a new position in shares of Vicarious Surgical in the 4th quarter valued at about $27,000. Finally, Connective Capital Management LLC acquired a new position in shares of Vicarious Surgical during the third quarter worth about $169,000. 47.27% of the stock is currently owned by institutional investors and hedge funds.

Vicarious Surgical Company Profile

Vicarious Surgical develops a next-generation robotic surgical system that integrates virtual reality (VR) with minimally invasive instrumentation. Its flagship offering combines ultra-slender, articulated robotic arms with a VR surgeon console, allowing physicians to perform laparoscopic procedures with enhanced precision, dexterity and visual immersion. The platform is designed to reduce patient trauma compared with traditional open or laparoscopic surgery and to expand surgeon access to challenging operative sites.

The company’s technology is intended for use across multiple surgical specialties, including general surgery, gynecology and urology.